Skip to main content

JHOP - March 2022 Vol 12 Special Feature

Download Editorial PDF
Download Hopa Abstracts PDF

HOP(A) Springs Eternal

By Bryna Delman Ewachiw, PharmD, BCOP; Mark L. Zangardi, PharmD, BCOP

A Pooled Safety Analysis of Loncastuximab Tesirine in Relapsed or Refractory DLBCL in the LOTIS Clinical Trial Program: Incidence, Onset, and Management of Myelosuppression

Evaluation of Empiric Double Coverage with Tobramycin for Adult Patients with Febrile Neutropenia

Treatment Patterns, Real-World Outcomes, and Resource Use in Patients with Non–MSI-High or Mismatch Repair Proficient Advanced Endometrial Cancer

Development and Implementation of a Pharmacist-Led Virtual Clinic Improve the Management of Patients with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors

Impact of a Remote Oncology Clinical Pharmacist Program in 4 Community Oncology Practices

Impact of PGY2 Oncology Pharmacy Residents’ Learning Experiences During the COVID-19 Pandemic

Integrated Health-System Specialty Pharmacy Support in Reducing Financial Toxicity of Oral Oncolytic Therapy

Perceptions of PGY2 Oncology Programs on Financial Toxicity Education and Preparedness

Pharmacist-Led Oral Chemotherapy Monitoring Pilot Study and Assessment of Patient-Reported Outcomes and Adherence

The Impact of a Comprehensive Immunotherapy Continuing Education Curriculum on Pharmacists’ Knowledge, Competence, and Confidence

Effect of Concomitant Azole Antifungals on Duration of Myelosuppression in Newly Diagnosed Patients with AML Receiving Venetoclax in Combination with Cladribine and Low-Dose Cytarabine

The Safety of FOLFIRINOX Regimen: Oxaliplatin and Irinotecan Sequence of Administration

Evaluation of the Reliability of 5-FU Elastomeric Pump in an Ambulatory Infusion Center

Time to Treatment Initiation and Outcomes for Patients with Nonmetastatic Breast Cancer Before and During the COVID-19 Pandemic at Community Cancer Centers